Skip to main content

Asuragen to Manufacture RNA Control Kits for Affy-Based Tests


By Justin Petrone

Asuragen said last week that it will develop and manufacture RNA control kits for Affymetrix.

The control kits are intended for use with Asuragen-made in vitro transcription reagent kits for clinical molecular diagnostic applications that run on the Affy platform.

Austin, Tex.-based Asuragen said the kits will be configured for use with the GeneChip System 3000Dx version 2, and will be made available to companies developing and commercializing tests on the GeneChip platform. There are currently more than 20 different molecular assay tests based on the Affy platform under development by Affy and 11 partners, Asuragen said.

Asuragen inked a deal to manufacture in vitro transcription reagent kits for use with Affy's diagnostic microarray platform in July 2008 (see BAN 7/8/2008). The companies have also cooperated on other products. Asuragen began offering DiscovArray, an Affy-manufactured chip for microRNA expression profiling, in 2007 (see BAN 8/7/2007).

Financial details of the new agreement were not discussed.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.